Radiotherapy versus Endolaryngeal Laser Resection for Early Stage Glottic Cancer: a Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000362

Enrollment

Unknown

Registered

2009-03-31

Start date

2009-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glottic cancer

Interventions

laser resection:endolaryngeal laser resection

radiotherapy:radiotherapy ,6MV-X, 66-70 Gy/6.5-7 week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: T1: Tumor limited to the vocal cord (s) (may involve anterior or posterior commissure) with normal mobility

Exclusion criteria

Exclusion criteria: 1. T2, T3, T3 glottic cancer; 2. supraglottic or subglottic cancer; 3. patients refused to participate; 4. patients that can't guarantee to follow up

Design outcomes

Primary

Measure	Time frame
survival rate;	—

Secondary

Measure	Time frame
quality of life and voice;medical cost;	—

Countries

China

Contacts

Public ContactYasinjan Abdurehim

ysj0991@126.com+86 0 13609911201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026